Improved tumour control probability with MRI-based prostate brachytherapy treatment planning

References

• Zietman AL, DeSilvio ML, Slater JD, Rossi CJ, Jr., Miller DW, Adams JA, . Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005;294:1233–9.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Motohashi K, Bownes P, Bryant L, Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial. Radiother Oncol 2007;84:114–20.
   PubMed Web of Science ®Google Scholar
• Villeirs GM, Van VK, Vakaet L, Bral S, Claus F, De Neve WJ, . Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005;181:424–30.
   PubMed Web of Science ®Google Scholar
• Gao Z, Wilkins D, Eapen L, Morash C, Wassef Y, Gerig L. A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol 2007;85:239–46.
   PubMed Web of Science ®Google Scholar
• Debois M, Oyen R, Maes F, Verswijvel G, Gatti G, Bosmans H, . The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999;45:857–65.
   PubMed Web of Science ®Google Scholar
• Smith WL, Lewis C, Bauman G, Rodrigues G, D’Souza D, Ash R, . Prostate volume contouring: A 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 2007;67:1238–47.
   PubMed Web of Science ®Google Scholar
• Pieters BR, Geijsen ED, Koedooder K, Blank LE, Rezaie E, van der Grient JN, . Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011;79:1037–42.
   PubMed Web of Science ®Google Scholar
• Pieters BR, van der Grient JN, Blank LE, Koedooder K, Hulshof MC, de Reijke TM. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. Radiother Oncol 2006;80:69–72.
   PubMed Web of Science ®Google Scholar
• van’t Riet A, Mak AC, Moerland MA, Elders LH, van der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate. Int J Radiat Oncol Biol Phys 1997;37:731–6.
   PubMed Web of Science ®Google Scholar
• Van der Laarse R, Luthmann RW. Computers in brachytherapy dosimetry. In: Joslin CAF, Flynn A, Hall EJ, editors. Principles and practice of brachytherapy using afterloading systems. London: Arnold; 2001. p. 49–80.
   Google Scholar
• Moerland MA, van der Laarse R, Luthmann RW, Wijrdeman HK, Battermann JJ. The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. Radiother Oncol 2000;57:279–84.
   PubMed Web of Science ®Google Scholar
• Dale RG. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day. Br J Radiol 1986;59:919–27.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005;44:265–76.
   PubMed Web of Science ®Google Scholar
• Gao M, Mayr NA, Huang Z, Zhang H, Wang JZ. When tumor repopulation starts?The onset time of prostate cancer during radiation therapy. Acta Oncol 2010;49: 1269–75.
   Google Scholar
• Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6–13.
   PubMed Web of Science ®Google Scholar
• Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low?Int J Radiat Oncol Biol Phys 2001;50: 1021–31.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Guerrero M, Li XA. How low is the alpha/beta ratio for prostate cancer?Int J Radiat Oncol Biol Phys 2003;55:194–203.
   PubMed Web of Science ®Google Scholar
• Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 2003;57:391–401.
   PubMed Web of Science ®Google Scholar
• Carlone M, Wilkins D, Raaphorst GP. Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: In regard to D’Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540–1548). Int J Radiat Oncol Biol Phys 2005;62:298–9.
   PubMed Web of Science ®Google Scholar
• Liu D, Usmani N, Ghosh S, Kamal W, Pedersen J, Pervez N, . Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images. Brachytherapy 2012;11:284–91.
   PubMed Web of Science ®Google Scholar
• Parker CC, Damyanovich A, Haycocks T, Haider M, Bayley A, Catton CN. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 2003;66:217–24.
   PubMed Web of Science ®Google Scholar
• De Brabandere M, Hoskin P, Haustermans K, Van den Heuvel F, Siebert FA. Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion. Radiother Oncol 2012;104:192–8.
   PubMed Web of Science ®Google Scholar
• Rasch C, Barillot I, Remeijer P, Touw A, van HM, Lebesque JV. Definition of the prostate in CT and MRI: A multi-observer study. Int J Radiat Oncol Biol Phys 1999;43:57–66.
   PubMed Web of Science ®Google Scholar
• Roach M, Faillace-Akazawa P, Malfatti C, Holland J. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:1011–8.
   PubMed Web of Science ®Google Scholar
• Prete JJ, Prestidge BR, Bice WS, Dubois DF. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 1998;6:90–6.
   PubMedGoogle Scholar
• Usmani N, Sloboda R, Kamal W, Ghosh S, Pervez N, Pedersen J, . Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?Int J Radiat Oncol Biol Phys 2011;80:728–34.
   PubMed Web of Science ®Google Scholar
• Acher P, Rhode K, Morris S, Gaya A, Miquel M, Popert R, . Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants. Int J Radiat Oncol Biol Phys 2008;71:1518–25.
   PubMed Web of Science ®Google Scholar
• Petrik D, Araujo C, Kim D, Halperin R, Crook JM. Implications of CT imaging for postplan quality assessment in prostate brachytherapy. Brachytherapy 2012;11: 435–40.
   PubMed Web of Science ®Google Scholar
• Aoki M, Yorozu A, Dokiya T. Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds. Jpn J Radiol 2009;27:410–5.
   PubMed Web of Science ®Google Scholar
• Ho AY, Burri RJ, Cesaretti JA, Stone NN, Stock RG. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:16–22.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, . Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007;67:327–33.
   PubMed Web of Science ®Google Scholar
• Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer 2000;89:1800–9.
   PubMed Web of Science ®Google Scholar
• Merrick GS, Gutman S, Andreini H, Taubenslag W, Lindert DL, Curtis R, . Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. Eur Urol 2007;52:715–23.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Davis A, Vargas SO, Renshaw AA, Jiroutek M, Richie JP. Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?Int J Radiat Oncol Biol Phys 1999;43:587–90.
   PubMed Web of Science ®Google Scholar
• Steenbakkers RJ, Duppen JC, Betgen A, Lotz HT, Remeijer P, Fitton I, . Impact of knee support and shape of tabletop on rectum and prostate position. Int J Radiat Oncol Biol Phys 2004;60:1364–72.
   PubMed Web of Science ®Google Scholar
• Lindsay PE, Moiseenko VV, Van DJ, Battista JJ. The influence of brachytherapy dose heterogeneity on estimates of alpha/beta for prostate cancer. Phys Med Biol 2003;48:507–22.
   PubMed Web of Science ®Google Scholar
• D’Souza WD, Thames HD, Kuban DA. Dose-volume conundrum for response of prostate cancer to brachytherapy: Summary dosimetric measures and their relationship to tumor control probability. Int J Radiat Oncol Biol Phys 2004;58:1540–8.
   PubMed Web of Science ®Google Scholar